Latest filing published 23 Jan 2019 for Karo Pharma AB, €2.1M.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Per Håkan Albin Åström: trading record in brief
Per Håkan Albin Åström discloses dealings in Karo Pharma AB to Finansinspektionen. We count 3 filings; the first trade dates from 6 March 2018 and the latest from 22 January 2019.
Both buying and selling appear: 1 purchase worth €168k, against 1 sale worth €2.1M. Sales outweigh purchases by €1.9M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2019, the count stands at no purchases and 1 sale.
The record was last updated on 23 January 2019 with an open-market sale (€2.1M) in Karo Pharma AB. The last purchase on record was published on 6 March 2018, which is 3,168 days ago. Filings reach the Finansinspektionen feed a median of 1 day after the trade. Under the Market Abuse Regulation, managers have three business days to notify their trades. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Companies and markets linked to Per Håkan Albin Åström
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 568,218 shares@ SEK 38.0077.6% of flowAktieISIN SE0007464888FI:csv-5959315cf61850b5c111
- 189,406 shares@ SEK 24.0016.2% of flowISIN SE0007464888FI:csv-3a42222bc8051116e5f5
- 50,000 shares@ SEK 34.266.2% of flowISIN SE0007464888FI:csv-c9eea407d369a0f54833Canonical exit: 4 Jun 2018 (T+90)
3 of 3 declarations